GB1228618A - - Google Patents
Info
- Publication number
- GB1228618A GB1228618A GB1228618DA GB1228618A GB 1228618 A GB1228618 A GB 1228618A GB 1228618D A GB1228618D A GB 1228618DA GB 1228618 A GB1228618 A GB 1228618A
- Authority
- GB
- United Kingdom
- Prior art keywords
- aug
- constituent
- components
- pharmaceutical compositions
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 2
- 239000000470 constituent Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 abstract 1
- LBXHRAWDUMTPSE-AOOOYVTPSA-N 4-chloro-N-[(2S,6R)-2,6-dimethyl-1-piperidinyl]-3-sulfamoylbenzamide Chemical compound C[C@H]1CCC[C@@H](C)N1NC(=O)C1=CC=C(Cl)C(S(N)(=O)=O)=C1 LBXHRAWDUMTPSE-AOOOYVTPSA-N 0.000 abstract 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 abstract 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 abstract 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229960004070 clopamide Drugs 0.000 abstract 1
- LIMAOLZSWRJOMG-HJPBWRTMSA-N dihydroergocristine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](C(N21)=O)(NC(=O)[C@H]1CN(C)[C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C(C)C)C1=CC=CC=C1 LIMAOLZSWRJOMG-HJPBWRTMSA-N 0.000 abstract 1
- 229960004318 dihydroergocristine Drugs 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 150000003840 hydrochlorides Chemical class 0.000 abstract 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 abstract 1
- 229960003147 reserpine Drugs 0.000 abstract 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1160367 | 1967-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1228618A true GB1228618A (enExample) | 1971-04-15 |
Family
ID=4375076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1228618D Expired GB1228618A (enExample) | 1967-08-17 | 1968-08-15 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3567828A (enExample) |
| BE (1) | BE719604A (enExample) |
| DE (1) | DE1792271C3 (enExample) |
| ES (1) | ES357294A1 (enExample) |
| FR (1) | FR7944M (enExample) |
| GB (1) | GB1228618A (enExample) |
| MY (1) | MY7400206A (enExample) |
| SE (1) | SE351565B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2138678A (en) * | 1983-04-22 | 1984-10-31 | Sandoz Ltd | Pharmaceutical composition comprising co-dergocrine |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2930369A1 (de) * | 1979-07-26 | 1981-02-05 | Rentschler Arzneimittel | Arzneimittelloesungen |
-
1968
- 1968-08-12 US US751751A patent/US3567828A/en not_active Expired - Lifetime
- 1968-08-12 SE SE10831/68A patent/SE351565B/xx unknown
- 1968-08-13 DE DE1792271A patent/DE1792271C3/de not_active Expired
- 1968-08-14 FR FR163039A patent/FR7944M/fr not_active Expired
- 1968-08-15 GB GB1228618D patent/GB1228618A/en not_active Expired
- 1968-08-16 BE BE719604D patent/BE719604A/xx not_active IP Right Cessation
- 1968-08-16 ES ES357294A patent/ES357294A1/es not_active Expired
-
1974
- 1974-12-30 MY MY206/74A patent/MY7400206A/xx unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2138678A (en) * | 1983-04-22 | 1984-10-31 | Sandoz Ltd | Pharmaceutical composition comprising co-dergocrine |
| US4617306A (en) * | 1983-04-22 | 1986-10-14 | Sandoz Ltd. | Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist |
| AU571218B2 (en) * | 1983-04-22 | 1988-04-14 | Sandoz Ltd. | Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist |
| US4797404A (en) * | 1983-04-22 | 1989-01-10 | Sandoz Ltd. | Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist |
| AT393625B (de) * | 1983-04-22 | 1991-11-25 | Sandoz Ag | Verfahren zur herstellung eines neuen therapeutischen praeparates enthaltend co-dergocrine und einen calciumantagonisten |
Also Published As
| Publication number | Publication date |
|---|---|
| BE719604A (enExample) | 1969-02-17 |
| DE1792271B2 (de) | 1979-01-04 |
| FR7944M (enExample) | 1970-05-25 |
| DE1792271A1 (de) | 1971-11-11 |
| MY7400206A (en) | 1974-12-31 |
| US3567828A (en) | 1971-03-02 |
| ES357294A1 (es) | 1970-03-16 |
| SE351565B (enExample) | 1972-12-04 |
| DE1792271C3 (de) | 1982-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101177A (en) | Improvements in pharmaceutically acceptable salts | |
| MXPA02007931A (es) | Analogos de nucleosido con base monociclica modificada con carboxamidina. | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| IL90435A (en) | 4-(quinoline-2-yl-methoxy) phenylacetic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| PT86186A (en) | Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same | |
| ES346635A1 (es) | Un nuevo procedimiento para la obtencion de 2-arilamino-1,3-diazaciclo-alquenos-(2). | |
| GB1247801A (en) | Pharmaceutical compositions | |
| GB1491503A (en) | Method of preventing and treating thrombosis | |
| ES357294A1 (es) | Procedimiento para la produccion de composiciones reducto- ras de la presion sanguinea. | |
| GB1441017A (en) | Ophthalmological medicaments | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| GB1229400A (enExample) | ||
| GB1175430A (en) | Pharmaceutical Compositions containing Ergot Alkaloids | |
| ES469020A1 (es) | Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos | |
| GB1341376A (en) | Pharmaceutical compositions comprising 4-methyl-5-2-aminoethyl imidazole | |
| GB1051686A (enExample) | ||
| GB1535778A (en) | Compounds useful in treatment of unipolar depression | |
| KR870010080A (ko) | 면역촉진 활성을 갖는 트리펩티드 | |
| ES361664A1 (es) | Procedimiento para la preparacion de nuevo acido antrani- lico. | |
| GB904955A (en) | Pharmaceutical compositions containing phloroglucinol | |
| GB1454390A (en) | Nasal decongestants | |
| ES368396A1 (es) | Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos. | |
| GB1327465A (en) | Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase | |
| ES363792A1 (es) | Procedimiento para la elaboracion de bisulfanilamina triha-logenopiridinas. | |
| GB1262140A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE20 | Patent expired after termination of 20 years |